Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Pathikrit Bose

Is Cardlytics Stock a Buy After Insider's $13.9M Investment?

Top insiders within a company buying its stock can be a bullish sign. These insiders - a group that includes CEOs, board directors, and major shareholders - likely have a deeper understanding of the company's financial health and strategic plans than the average investor. So, their insider purchases might suggest they believe the stock is undervalued.

One stock that has been the target of heavy insider buying lately is Cardlytics (CDLX), with a major stakeholder dropping multi-millions on the shares this March after a long period of inactivity. At the same time, CDLX shares have been unusually volatile. Could there be more upside in store? Let's take a closer look.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.